about
Filamentous bacteriophage fd as an antigen delivery system in vaccinationCo-immunization with multimeric scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cellsUse of fusion proteins and procaryotic display systems for delivery of HIV-1 antigens: development of novel vaccines for HIV-1 infection.New recombinant vaccines based on the use of prokaryotic antigen-display systems.Triggering DTH and CTL activity by fd filamentous bacteriophages: role of CD4+ T cells in memory responses.Alum and squalene-oil-in-water emulsion enhance the titer and avidity of anti-Aβ antibodies induced by multimeric protein antigen (1-11)E2, preserving the Igg1-skewed isotype distributionMassive-scale RNA-Seq analysis of non ribosomal transcriptome in human trisomy 21.HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses in the absence of IFNγ production by CD4+ T cells.Stimulation of Innate and Adaptive Immunity by Using Filamentous Bacteriophage fd Targeted to DEC-205Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response.Novel antigen delivery systems.E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cellsDelivery strategies for novel vaccine formulations.Distinct Antigen Delivery Systems Induce Dendritic Cells' Divergent Transcriptional Response: New Insights from a Comparative and Reproducible Computational Analysis.Memory immune response: a major challenge in vaccination.Analysis of SEMA6B gene expression in breast cancer: identification of a new isoform.Comparative analysis of new innovative vaccine formulations based on the use of procaryotic display systems.Human naive CD4 T-cell clones specific for HIV envelope persist for years in vivo in the absence of antigenic challenge.Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments.Induction of specific T-helper and cytolytic responses to epitopes displayed on a virus-like protein scaffold derived from the pyruvate dehydrogenase multienzyme complex.A multimeric immunogen for the induction of immune memory to beta-amyloid.HIV Vaccination: A Roadmap among Advancements and Concerns.Vaccination With Recombinant Filamentous fd Phages Against Parasite Infection Requires TLR9 Expression.Phage display of a CTL epitope elicits a long-term in vivo cytotoxic responseImmunostimulatory Phosphatidylmonogalactosyldiacylglycerols (PGDG) from the Marine Diatom : Inspiration for a Novel Synthetic Toll-Like Receptor 4 AgonistInduction of human NK cell-mediated cytotoxicity by CD40 triggering on antigen presenting cellsVaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T-cell responses in the absence of adjuvantsVectorized Delivery of Alpha-GalactosylCeramide and Tumor Antigen on Filamentous Bacteriophage fd Induces Protective Immunity by Enhancing Tumor-Specific T Cell Response
P50
Q26864071-99F4DE13-0978-43C6-9B4D-9F4DA563B745Q28732043-EC441535-74AB-45A9-A04B-4E588906DC39Q33200442-5AF693C6-9261-41BC-B254-3F1990371284Q33210092-7F1CB5C2-002E-42A3-9F3E-E1E6C33414CEQ33821476-D9AF8011-3E3E-4799-B42D-93EB320A6B04Q33831036-A1181351-A168-47DB-8295-63D28C39FAAEQ33886396-6AF7DDED-2E12-43C0-B16E-1F74C4B31397Q35745815-4F782479-7A7A-4B67-B5B8-9B7F3D257616Q35778958-45E0B56A-48A9-427C-ADD9-12280A1E2E24Q35904260-8C12BA2E-C1A8-426A-9122-3DC04AE8545FQ35947894-743E1F6B-2A87-4951-BB31-B3DB5F833101Q36078930-580DD8E5-83FD-4D92-9E35-2C7DE2BE58B5Q37195521-1C1BEB1A-23E1-4FC1-8796-DEE59AAB56EDQ37729017-2C936B33-9251-4138-B1F5-79127CE0030EQ38273080-86F7B1A0-4111-4D9E-89A9-8031930553CFQ39153302-81FDC9C7-15A5-488F-AAFC-28D978ABEF13Q40180706-8AE4D164-96DC-49D3-9E13-5092032611D3Q40368533-58AF8AAD-1CE4-4FDF-B1F5-53B11969FCD4Q43848873-B2696FF3-A2B0-4E7B-AFDF-03C9AAC53268Q44341808-61EE4B04-B6B2-4DCB-AA4A-AEC6DFF6008AQ51029695-B37103BA-C16B-4985-9C86-B93C5C4DAAEAQ54232567-A8602351-F2A6-47C9-B09B-58C1453F3DE2Q55094740-C4AA35FB-0998-4374-BC1F-E64CE08D57EEQ56894278-41CBD2A1-AE5E-4B22-BCDF-26A91DB84432Q64250640-8F6A484A-8812-4491-9433-19FA4FA9E15AQ73396670-8D5BC754-B4C0-431D-87E9-0D6704258D3EQ84396239-C4FF0577-A62C-4E83-B0E6-074FC422A021Q90012569-A2F308DC-4BF3-4FB2-A3E1-4E6A5A6A9B8B
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Piergiuseppe De Berardinis
@ast
Piergiuseppe De Berardinis
@en
Piergiuseppe De Berardinis
@es
Piergiuseppe De Berardinis
@nl
Piergiuseppe De Berardinis
@sl
type
label
Piergiuseppe De Berardinis
@ast
Piergiuseppe De Berardinis
@en
Piergiuseppe De Berardinis
@es
Piergiuseppe De Berardinis
@nl
Piergiuseppe De Berardinis
@sl
prefLabel
Piergiuseppe De Berardinis
@ast
Piergiuseppe De Berardinis
@en
Piergiuseppe De Berardinis
@es
Piergiuseppe De Berardinis
@nl
Piergiuseppe De Berardinis
@sl
P106
P21
P2798
P31
P496
0000-0001-6579-1729